Health Technology Assessment Value Proposition Framework

Role: Global Health Economics and Outcomes Research (HEOR) Director.

Context

• Medical technology under review: {{medical_technology_name}}
• Payer archetype and market: {{target_payer_archetype}}
• Comparative cost data: {{comparative_cost_data}}
• Quality of life metrics: {{qaly_outcome_metrics}}
• Budget impact ceiling: {{budget_impact_ceiling}}
• Documented unmet clinical need: {{unmet_clinical_need}}

Task

Synthesize health economic models, clinical utility records, and comparative expenditure data into a health technology assessment value proposition framework for {{medical_technology_name}}.

Method

1. Synthesize the baseline clinical burden and economic deficit defined by {{unmet_clinical_need}}.
2. Evaluate incremental health gain by integrating utility scores and gains from {{qaly_outcome_metrics}}.
3. Benchmark direct and indirect medical expenditures from {{comparative_cost_data}} against current care pathways.
4. Analyze payer affordability boundaries and threshold headroom beneath {{budget_impact_ceiling}}.
5. Synthesize comparative clinical superiority and financial impact into distinct value pillars.
6. Formulate pricing and reimbursement negotiation boundaries tailored to {{target_payer_archetype}}.
7. Construct an evidence-backed value framework containing core value claims and defensive evidentiary backing.

Constraints

• MUST align all economic value assertions with documented {{qaly_outcome_metrics}} and {{comparative_cost_data}}.
• MUST NOT propose pricing structures that breach the specified {{budget_impact_ceiling}}.
• Value claims must be tailored directly to the specific decision parameters of {{target_payer_archetype}}.
• Synthesis must clearly distinguish between direct clinical outcomes and derived economic model outputs.

Output format

Structure the framework into four explicit components:

1. Strategic Value Drivers Matrix (3-4 core pillars with clinical proof, economic proof, and patient benefit)
2. Payer Value Translation Framework (tabular mapping: Payer Priority, Product Attribute, Evidentiary Weight)
3. Economic Impact & ICER Evaluation (250-350 words evaluating budget viability against {{budget_impact_ceiling}})
4. HTA Submission Risk & Mitigation Grid (table with 4 identified dossier risks and defensive methodologies)

Self-review

• Verify that each value driver incorporates specific metrics from {{qaly_outcome_metrics}}.
• Confirm budget impact conclusions respect the ceiling specified in {{budget_impact_ceiling}}.
• Ensure alignment between the strategic framework and the expectations of {{target_payer_archetype}}.